Cargando…
Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264462/ http://dx.doi.org/10.1038/bjc.2014.627 |
| _version_ | 1782348748973670400 |
|---|---|
| author | Suttle, A B Ball, H A Molimard, M Hutson, T E Carpenter, C Rajagopalan, D Lin, Y Swann, S Amado, R Pandite, L |
| author_facet | Suttle, A B Ball, H A Molimard, M Hutson, T E Carpenter, C Rajagopalan, D Lin, Y Swann, S Amado, R Pandite, L |
| author_sort | Suttle, A B |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4264462 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42644622015-04-29 Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma Suttle, A B Ball, H A Molimard, M Hutson, T E Carpenter, C Rajagopalan, D Lin, Y Swann, S Amado, R Pandite, L Br J Cancer Erratum Nature Publishing Group 2014-12-09 2014-12-09 /pmc/articles/PMC4264462/ http://dx.doi.org/10.1038/bjc.2014.627 Text en Copyright © 2014 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ |
| spellingShingle | Erratum Suttle, A B Ball, H A Molimard, M Hutson, T E Carpenter, C Rajagopalan, D Lin, Y Swann, S Amado, R Pandite, L Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma |
| title | Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma |
| title_full | Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma |
| title_fullStr | Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma |
| title_full_unstemmed | Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma |
| title_short | Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma |
| title_sort | relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264462/ http://dx.doi.org/10.1038/bjc.2014.627 |
| work_keys_str_mv | AT suttleab relationshipsbetweenpazopanibexposureandclinicalsafetyandefficacyinpatientswithadvancedrenalcellcarcinoma AT ballha relationshipsbetweenpazopanibexposureandclinicalsafetyandefficacyinpatientswithadvancedrenalcellcarcinoma AT molimardm relationshipsbetweenpazopanibexposureandclinicalsafetyandefficacyinpatientswithadvancedrenalcellcarcinoma AT hutsonte relationshipsbetweenpazopanibexposureandclinicalsafetyandefficacyinpatientswithadvancedrenalcellcarcinoma AT carpenterc relationshipsbetweenpazopanibexposureandclinicalsafetyandefficacyinpatientswithadvancedrenalcellcarcinoma AT rajagopaland relationshipsbetweenpazopanibexposureandclinicalsafetyandefficacyinpatientswithadvancedrenalcellcarcinoma AT liny relationshipsbetweenpazopanibexposureandclinicalsafetyandefficacyinpatientswithadvancedrenalcellcarcinoma AT swanns relationshipsbetweenpazopanibexposureandclinicalsafetyandefficacyinpatientswithadvancedrenalcellcarcinoma AT amador relationshipsbetweenpazopanibexposureandclinicalsafetyandefficacyinpatientswithadvancedrenalcellcarcinoma AT panditel relationshipsbetweenpazopanibexposureandclinicalsafetyandefficacyinpatientswithadvancedrenalcellcarcinoma |